左西孟旦对左心功能衰竭患者血浆N-末端脑钠肽前体水平的影响
被引量:3
摘要
左西孟旦作为新型正性肌力药一钙增敏剂的一种,由于其具有增加心肌收缩力而不增加心率和心肌耗氧量等优点,被认为很有临床应用前景的新药。
出处
《中国基层医药》
CAS
2012年第10期1545-1546,共2页
Chinese Journal of Primary Medicine and Pharmacy
参考文献5
-
1李玮伟,陈杰,王祥瑞.新型正性肌力药左西孟旦的作用机制及临床应用[J].国际麻醉学与复苏杂志,2008,29(6):517-519. 被引量:9
-
2纪木火,李仁奇,张庆伟,杨建军.钙增敏剂左西孟旦的研究进展[J].药学与临床研究,2010,18(5):458-461. 被引量:12
-
3Nieminen M. Levosimendan in Patients with Left Heart Failure After Acute Myocardial Infarction-Review of the RUSSLAN Study and Future Developments with Levosimendan. J Fur Kardiol, 2011,9 ( 3 ) :45-48.
-
4刘爱华,王绪芳,韩桂云.脑钠肽和NT—Pro BNP检测在心力衰竭诊断中的意义[J].中国基层医药,2011,18(8):1038-1040. 被引量:35
-
5Dao Q, Krishnaswamy P, Kazanegra R, et al. Utilty of B-rype natriuretic peptide in the diagnosis of congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coil Cardial, 2001,37(2) :379-385.
二级参考文献71
-
1印小荣,段宝祥,何晓虹,张幼祥,李蓬.脑钠素对心功能不全的诊断价值[J].中国现代医药杂志,2005,7(6):8-11. 被引量:5
-
2Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology, 2006, 104: 556-569.
-
3Haikala H, Nissinen E, Etemadzadeh E, et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol, 1995, 25: 794-801.
-
4Jonsson EN, Antila S, McFadyen L, et al. Population pharmaeokinetics of levosimcndan in patients with congestive heart failure. Br J Clin Pharmacol, 2003, 55: 544-551.
-
5Antila S, Jarvinen A, Honkanen T, et al. Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosi- mendan and warfarin. Eur J Clin Pharmacol, 2000, 56: 705-710.
-
6Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels. Anesth Analg, 2000, 90: 5-11.
-
7Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther, 1999, 288: 316-325.
-
8Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) :a randomised double-blind trial. Lancet, 2002, 360: 196-202.
-
9Moiseyev VS, Poder P, Andrejevs N, ct al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebocontrolled, double-blind study (RUSSLAN). Eur Heart J, 2002, 23 : 1422-1432.
-
10Busk M, Maeng M, Kristensen J, et al. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model. Cardiovasc Drugs Ther, 2006, 20: 335- 342.
共引文献51
-
1刘亚平.重组人脑利钠肽治疗冠心病失代偿性心力衰竭的临床研究[J].中国基层医药,2012,19(4):569-570. 被引量:3
-
2朱礼鑫.血浆B型钠尿肽在冠心病严重程度及预后评估中的价值[J].中国现代医生,2012,50(11):33-34. 被引量:3
-
3尹刚,李越凡.左西孟旦治疗急性心肌梗死并心力衰竭的疗效观察[J].中国基层医药,2012,19(10):1546-1547. 被引量:7
-
4冼伟进,余泽洪,陈小林,汤立军,何北海,邹祎,区转换,陈秀英,梁美合.血栓抽吸导管在急性心肌梗死患者急诊经皮冠状动脉介入治疗中的应用[J].中国综合临床,2012,28(8):848-852. 被引量:7
-
5张司兰.培哚普利联合美托洛尔治疗老年人慢性心力衰竭[J].中国基层医药,2012,19(18):2751-2753. 被引量:5
-
6梁蕾,李娟,姜兰.B型钠尿肽在老年呼吸困难患者鉴别中的应用意义[J].中国医药指南,2012,10(27):150-151.
-
7宋永生.糖化血红蛋白和N末端脑钠肽原与急性冠脉综合征患者心功能的相关性研究[J].中国基层医药,2012,19(23):3541-3542. 被引量:5
-
8何卫华.厄贝沙坦联合美托洛尔治疗心力衰竭疗效分析及对血清脑钠肽水平的影响[J].中国基层医药,2012,19(22):3367-3368. 被引量:7
-
9徐丽霞,钟益芳.血浆脑钠肽水平检测对心房颤动的临床意义[J].中国基层医药,2013,20(10):1557-1558. 被引量:2
-
10滕志涛,陈聪,秦春新,潘延飞,郭志勇,赵培勇.左西孟旦对慢性收缩性心力衰竭患者左心室功能及最大摄氧量的影响[J].山东医药,2013,53(31):74-75. 被引量:9
同被引文献31
-
1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
-
2Kivikko M, Antila S, Eha J, et al. Pharmacokinetics of levosimen- dan and its metabolites during and after a 24-hour continuous in fusion in patients with severe heart failure. Int J Clin Pharmaeol Ther,2002,40(10) :465-471.
-
3Gheorghiade M,Teerlink JR, Mebazaa A. Pharmacology of new a- gents for the acute heart failure syndrome. Am J Cardio1,2005,96 (6) :68-73.
-
4Ng TM. Levosimendan,a new calcium-sensitizing inotrope for heart failure. Pharmacotherapy ,2004,24 ( 10 ) : 1366-1384.
-
5Mebazaa A, Erhardt L. Levosimendan : a new dual-action drug in the treatment of acute heart failure. Int J Clin Pract, 2003,57 (5) :410-416.
-
6Cleland JG, Nikitin N, McGowan J. Levosimendan:first in a new class of inodilator for acute and chronic severe heart failure. Ex-pert Rev Cardiovasc Ther,2004,2( 1 ) :9-19.
-
7Kaheinen P, Pollesello P, Levijoki J. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart. J Cardiovasc Pharmaco1,2004,43 (4) :555-561.
-
8Paraskevaidis IA, Parissis LIT, Th Kremastinos D. Anti-inflammato- ry and antiapoptotie effects of levosimendan in decompensated heart failure:a novel mechanism of drug-induced improvement in contractile performance of the failing heart. Curr Med Chem Card- iovase Hematol Agents ,2005,3 ( 3 ) :243-247.
-
9Michaels AD, McKeown B, Kostal M, et al. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ven- tricular wall stress, and myocardia loxygen uptake. Circulation, 2005,111 (12) : 1504-1509.
-
10Maytin M, Colucci WS. Cardioprotection:A new paradigm in the management of acute heart failure syndromes. Am J Cardiol, 2005,96 ( Suppl ) : 26 -31.
引证文献3
-
1郭辉荣,王东波,徐志勇.左西孟旦的作用机制及临床应用研究进展[J].中国基层医药,2012,19(23):3643-3644. 被引量:13
-
2陈奇.左西孟旦治疗慢性阻塞性肺疾病伴右心功能不全55例疗效研究[J].中国药业,2015,24(23):76-77. 被引量:6
-
3鲁明军,许玲玲,王敏,郑婷,苏楠.左西孟旦对扩张型心肌病失代偿患者N末端B型脑钠肽前体及心功能的影响[J].中国实用医药,2017,12(24):14-16.
二级引证文献19
-
1陆洋,张跃明,颜永进.左西孟旦对急性心力衰竭患者NT-proBNP和炎症反应标志物的影响[J].海南医学院学报,2013,19(11):1515-1517. 被引量:25
-
2左希宏,张艳玲,陈欢.左西孟旦治疗急性心肌梗死左心力衰竭患者的效果观察[J].中国综合临床,2014,30(1):52-54. 被引量:13
-
3王赛.左西孟旦在顽固性心力衰竭中的临床应用[J].中国实用医药,2014,9(25):32-33. 被引量:2
-
4宋永欣,李鹏,闫志兴,鲁召欣,官庆华,王君,安朋朋,张毅.左西孟旦治疗急性心力衰竭60例临床分析[J].中国基层医药,2014,21(24):3803-3805. 被引量:10
-
5张桂琴,王凌,李艳平,封红,张焱,张虎,马鲜云.CA125在识别慢性阻塞性肺疾病中右心衰的价值[J].临床医药文献电子杂志,2015,2(36):7511-7511.
-
6贾静涛.左西孟旦对慢性心力衰竭室性心律失常的影响[J].中国医药导报,2016,13(9):169-172. 被引量:5
-
7宋维鹏,国强华,贾红丹,宋婷婷,刘丽.左西孟旦对老年急性心肌梗死合并心衰患者心功能及hs-CRP、IL-6、TNF-α水平的影响[J].海南医学院学报,2016,22(12):1264-1266. 被引量:67
-
8石华民.左西孟旦治疗急性失代偿性心力衰竭效果观察[J].人民军医,2017,60(4):365-367. 被引量:1
-
9卓碧,韦庆新,韦盛锴,何柳,覃薪宇.不同剂量瑞舒伐他汀对急性心肌梗死患者经皮冠状动脉介入治疗术后血清炎症因子及心功能相关指标的影响[J].山西医药杂志,2017,46(13):1551-1553. 被引量:23
-
10潘晓鸿,陈园园,方强.脉搏指示连续心排量监测左西孟旦在急性心肌梗死合并心源性休克老年患者中的应用[J].中国老年学杂志,2018,38(3):519-521. 被引量:21
-
1徐慧敏.阵发性心房颤动患者血清N-末端脑钠肽前体水平变化及临床作用分析[J].中国医学工程,2014,22(1):131-131.
-
2杨静,武赞堂.慢性心力衰竭患者血清脂联素和N-末端脑钠肽前体水平及相关性分析[J].中国误诊学杂志,2012,12(10):2303-2303. 被引量:1
-
3童昕,陆润平,宛拥军,杨海军,曹铁松,朱胜兵,刘魁,丁建球,丁根明.芪苈强心胶囊对矽肺患者N-末端脑钠肽前体水平及心功能的影响[J].中华劳动卫生职业病杂志,2014,32(9):697-699. 被引量:6
-
4龙秀兰,任继刚,汪克纯,游波.左西孟坦治疗难治性心力衰竭的疗效分析[J].现代实用医学,2014,26(8):944-945. 被引量:13
-
5陈文,林文海.无症状心功能不全2型糖尿病患者的同型半胱氨酸与N-末端脑钠肽前体水平的相关性[J].实用医学杂志,2013,29(11):1813-1814. 被引量:6
-
6李晔,张恒.多巴胺、多巴酚丁胺治疗左心功能衰竭[J].辽宁药物与临床,1999,2(1):29-30.
-
7方洁.环磷腺苷葡胺对冠心病合并充血性心力衰竭患者N-末端脑钠肽前体水平及心功能的影响[J].中国医药导报,2010,7(31):61-62. 被引量:5
-
8陈丽聪,田建霞,王继苹.重症社区获得性肺炎患者N-末端脑钠肽前体水平与预后的关系[J].山西医药杂志,2014,43(24):2921-2922. 被引量:5
-
9杨曙光,王爱萍,汤学超,苏玉文,张杰,张代民.血浆N-末端脑钠肽前体水平与急性冠状动脉综合征严重程度的关系[J].解放军医学杂志,2007,32(11):1171-1173. 被引量:7
-
10杨帆,宁新惠,向小平.急性非ST段抬高性心肌梗死患者早期N-末端脑钠肽前体水平对其预后的影响[J].中国实用医药,2012,7(20):81-81. 被引量:1